122 related articles for article (PubMed ID: 19534603)
1. Usefulness of highly active antiretroviral therapy on health-related quality of life of adult recipients in Tanzania.
Magafu MG; Moji K; Igumbor EU; Hashizume M; Mizota T; Komazawa O; Cai G; Yamamoto T
AIDS Patient Care STDS; 2009 Jul; 23(7):563-70. PubMed ID: 19534603
[TBL] [Abstract][Full Text] [Related]
2. Non-communicable diseases in antiretroviral therapy recipients in Kagera Tanzania: a cross-sectional study.
Magafu MG; Moji K; Igumbor EU; Magafu NS; Mwandri M; Mwita JC; Habte D; Rwegerera GM; Hashizume M
Pan Afr Med J; 2013; 16():84. PubMed ID: 24711874
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study.
Louwagie GM; Bachmann MO; Meyer K; Booysen Fle R; Fairall LR; Heunis C
BMC Public Health; 2007 Sep; 7():244. PubMed ID: 17854510
[TBL] [Abstract][Full Text] [Related]
5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
7. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.
Memiah P; Shumba C; Etienne-Mesubi M; Agbor S; Hossain MB; Komba P; Niyang M; Biadgilign S
J Int Assoc Provid AIDS Care; 2014; 13(4):346-52. PubMed ID: 24114726
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
9. Predictors of weight loss after HAART initiation among HIV-infected adults in Tanzania.
Li N; Spiegelman D; Drain P; Mwiru RS; Mugusi F; Chalamilla G; Fawzi WW
AIDS; 2012 Mar; 26(5):577-85. PubMed ID: 22156968
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
Tozzi V; Balestra P; Murri R; Galgani S; Bellagamba R; Narciso P; Antinori A; Giulianelli M; Tosi G; Fantoni M; Sampaolesi A; Noto P; Ippolito G; Wu AW
Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
[TBL] [Abstract][Full Text] [Related]
11. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.
Memiah P; Shumba C; Etienne-Mesubi M; Agbor S; Hossain MB; Komba P; Niyang M; Biadgilign S
J Int Assoc Provid AIDS Care; 2014; 13(4):346-52. PubMed ID: 25513032
[TBL] [Abstract][Full Text] [Related]
12. [Adherence to HAART, quality of life and psychopathological symptoms among HIV/AIDS infected patients].
Margalho R; Pereira M; Ouakinin S; Canavarro MC
Acta Med Port; 2011 Dec; 24 Suppl 2():539-48. PubMed ID: 22849945
[TBL] [Abstract][Full Text] [Related]
13. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection.
Powers AE; Marden SF; McConnell R; Leidy NK; Campbell CM; Soeken KL; Barker C; Davey RT; Dybul MR
AIDS; 2006 Apr; 20(6):837-45. PubMed ID: 16549967
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in individuals infected with HIV in the era of HAART.
Miners AH; Sabin CA; Mocroft A; Youle M; Fisher M; Johnson M
HIV Clin Trials; 2001; 2(6):484-92. PubMed ID: 11742437
[TBL] [Abstract][Full Text] [Related]
17. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
[TBL] [Abstract][Full Text] [Related]
20. Predictors of health-related quality of life among military HIV-infected individuals.
Emuren L; Welles S; Macalino G; Evans AA; Polansky M; Ganesan A; Colombo RE; Agan BK;
Qual Life Res; 2020 Jul; 29(7):1855-1869. PubMed ID: 32076926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
